Vyome Holdings

Biotechnology
Vyome Holdings Inc is a clinical stage specialty pharmaceutical company working to treat immuno-inflammatory diseases including rare indications of unmet need with next-generation therapeutic solutions.

$29M

Market Cap • 10/15/2025

2025

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country